Skip to main content
. 2024 Sep 19;12(9):1075. doi: 10.3390/vaccines12091075

Figure 4.

Figure 4

Results of MR-MAP demand for scenarios 3 to 6 (scenarios 1 and 2 estimated potential demand if MR-MAPs were not made available and serve as the counterfactual).